| LDR | | 01670camuu22003734a 4500 |
| 001 | | 000013409665 |
| 005 | | 20100225104940 |
| 007 | | ta |
| 008 | | 080128s2008 enka b 001 0 eng |
| 010 | |
▼a 2008004048 |
| 020 | |
▼a 9780199211487 (pbk. : alk. paper) |
| 035 | |
▼a (KERIS)REF000014986565 |
| 040 | |
▼a DNLM/DLC
▼c DLC
▼d DLC
▼d 224010 |
| 042 | |
▼a pcc |
| 050 | 00 |
▼a RC268.4
▼b .P425 2008 |
| 060 | 10 |
▼a QZ 202
▼b P369m 2008 |
| 082 | 00 |
▼a 616.99/4071
▼2 22 |
| 090 | |
▼a 616.99
▼b P36mo2 |
| 093 | 1 |
▼a 4007406 |
| 100 | 1 |
▼a Pecorino, Lauren. |
| 245 | 10 |
▼a Molecular biology of cancer :
▼b mechanisms, targets, and therapeutics/
▼c Lauren Pecorino. |
| 250 | |
▼a 2nd ed. |
| 260 | |
▼a Oxford ;
▼a New York:
▼b Oxford University Press,
▼c 2008. |
| 300 | |
▼a xviii, 316 p.:
▼b ill. (some col.);
▼c 25 cm. |
| 504 | |
▼a Includes bibliographical references and index. |
| 505 | 0 |
▼a DNA structure and stability : mutations versus repair -- Regulation of gene expression -- Growth factor signaling and oncogenes -- The cell cycle -- Growth inhibition and tumor suppressor genes -- Apoptosis -- Stem cells and differentiation -- Metastasis -- Infections and inflammation -- Nutrients, hormones, and gene interactions -- The cancer industry : drug development and clinical trial design -- Cancer in the future : focus on diagnostics and immunotherapy. |
| 650 | 0 |
▼a Cancer
▼x Molecular aspects. |
| 650 | 0 |
▼a Cancer cells. |
| 650 | 12 |
▼a Neoplasms
▼x etiology. |
| 650 | 22 |
▼a Antineoplastic Agents
▼x therapeutic use. |
| 650 | 22 |
▼a Cell Transformation, Neoplastic
▼x genetics. |
| 650 | 22 |
▼a Neoplasms
▼x genetics. |
| 650 | 22 |
▼a Neoplasms
▼x therapy. |